Clinical and Economic Impact of Implementing OVIVA Criteria on Patients With Bone and Joint Infections in Outpatient Parenteral Antimicrobial Therapy

The OVIVA study demonstrated noninferiority for managing bone and joint infections (BJIs) with oral antibiotics. We report that 79.7% of OPAT patients being treated for BJIs at our center would be eligible for oral antibiotics, saving a median (IQR) 19.5 IV-antibiotic days (8.5–37) and GBP 1234 (569...

Descripción completa

Detalles Bibliográficos
Autores principales: Marks, Michael, Bell, Lucy C K, Jones, Imogen, Rampling, Tommy, Kranzer, Katharina, Morris-Jones, Stephen, Logan, Sarah, Pollara, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312207/
https://www.ncbi.nlm.nih.gov/pubmed/31603189
http://dx.doi.org/10.1093/cid/ciz991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312207/
https://www.ncbi.nlm.nih.gov/pubmed/31603189
http://dx.doi.org/10.1093/cid/ciz991

Ejemplares similares